Nephrocare Health Services Limited (NSE:NEPHROPLUS)
India · Delayed Price · Currency is INR 765.35
+18.10 (2.42%)
At close: Sep 11, 2026
NSE:NEPHROPLUS Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, NSE:NEPHROPLUS stock has a consensus rating of "Strong Buy" and an average price target of ₹847.50. The average 1-year stock price forecast is 10.73% higher than the current stock price, while the lowest is ₹780.00 (+1.91%) and the highest is ₹1,000 (+30.66%).
Price Target: ₹847.50 (+10.73%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for NSE:NEPHROPLUS stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 2 | 2 | 2 |
| Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 2 | 4 | 4 | 4 |
Financial Forecast
Revenue This Year
12.12B
from 9.99B
Increased by 21.38%
Revenue Next Year
14.49B
from 12.12B
Increased by 19.54%
EPS This Year
15.84
from 8.10
Increased by 95.52%
EPS Next Year
21.13
from 15.84
Increased by 33.43%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.